Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 17/20 | 0.79 |
| ▸ | PROKR1 | Q8TCW9 | 17/20 | 0.79 |
| ▸ | NAAA | Q02083 | 2/20 | 0.70 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15550157 | 0.91 | FPR2 (0.83) | FPR2PROKR1NAAA | |
| SCHEMBL15549622 | 0.89 | FPR2 (0.81) | FPR2PROKR1NAAA | |
| SCHEMBL15549719 | 0.88 | FPR2 (0.80) | FPR2PROKR1NAAA | |
| SCHEMBL15550205 | 0.88 | FPR2 (1.00) | FPR2PROKR1 | |
| SCHEMBL15537207 | 0.88 | FPR2 (1.00) | FPR2PROKR1NAAA | |
| SCHEMBL15548996 | 0.87 | FPR2 (0.77) | FPR2PROKR1NAAA | |
| SCHEMBL15547575 | 0.86 | FPR2 (0.80) | FPR2PROKR1NAAAMEN1CYP2C19 | |
| SCHEMBL15536944 | 0.85 | PROKR1 (1.00) | FPR2PROKR1NAAA | |
| SCHEMBL15549087 | 0.85 | FPR2 (0.70) | FPR2PROKR1NAAA | |
| SCHEMBL15549545 | 0.85 | FPR2 (1.00) | FPR2PROKR1NAAAMEN1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2855449-B1 | SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES | TAKEDA PHARMACEUTICALS CO (JP) | 2018-03-07 | — | — | EP | claimed |
| EP-2855449-A1 | SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES | Takeda Pharmaceutical Company Limited (JP) | 2015-04-08 | — | — | EP | claimed |
| WO-2013179024-A1 | SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-12-05 | — | — | WO | claimed |
| EP-2855449-A1 | SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES | Takeda Pharmaceutical Company Limited (JP) | 2015-04-08 | — | — | EP | disclosed |
| WO-2013179024-A1 | SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-12-05 | — | — | WO | disclosed |